Implantable type low-consumption wireless blood glucose monitor

Abstract

The invention discloses an implantable type low-consumption wireless blood glucose monitor. The implantable type low-consumption wireless blood glucose monitor comprises an in-vivo implantable assembly and an in-vitro assembly, wherein the in-vivo implantable assembly comprises an implantable type glucose sensor, the implantable type glucose sensor is connected with a signal processing circuit, the signal processing circuit is connected with a microprocessor, the microprocessor is connected with a first wireless communication module, the implantable type glucose sensor, the signal processing circuit, the microprocessor and the first wireless communication module are all connected with a power supply module, and the signal processing circuit, the microprocessor, the first wireless communication module and the power supply module are all coated in a shell; the in-vitro assembly comprises a second wireless communication module and an upper computer, and the second wireless communication module is connected with the upper computer. By adopting the technical scheme disclosed by the invention, the continuous real-time detection problem of glucose is solved, the dynamic monitoring of the blood glucose level of a diabetic patient is realized, and great assistance can be provided for treating the diabetic patient.

Description

technical field [0001] The invention belongs to the technical field of biochemical detection and implanted medical instruments, and in particular relates to an implanted low-power wireless blood glucose monitor. Background technique [0002] Diabetes is an endocrine and metabolic disorder caused by insulin deficiency. The early symptoms are loss of control over blood sugar concentration, which then leads to a series of syndromes (blindness, renal failure, etc.), and even endangers the patient's life. Diabetes is a worldwide frequently-occurring and common disease, and its incidence has shown an obvious upward trend in recent years. The incidence rate in my country has reached 2.5-3%, which is very close to 2-5% in developed countries in Europe and America. Today, there are about 50 million patients in my country and more than 200 million patients in the world. Diabetes has become a global health care problem and seriously threatens human health. It has become the third larg...

AI Technical Summary

Problems solved by technology

The biggest shortcoming of the invasive measurement method is that it cannot realize the dynamic detection of the blood glucose concentration of the human body, and cannot obtain the real-time changes of the blood glucose concentration of the patient, which is unfavorable for the effective treatment of diabetes

[0004] In order to realize the dynamic and continuous detection of blood glucose concentration, non-invasive methods of in vitro optical detection and minimally invasive methods of transdermal extraction to detect glucose concentration in interstitial fluid have appeared, but these detection methods have problems such as insufficient detection accuracy and low reliability. , still in the research stage, with little clinical application

Images